Unfortunately working to counter my paper losses however hope some hard questions are asked such as
- how are they going to increase revenue rapidly
- updates on the strong pipeline of US commercial opportunities
- updates on existing trials and contracts ex: DOD
- FDA approval
- Reimbursement US
- They have stated that medicare coverage in Aus isn't particularly important. That would appear to be contrary to reality going by the revenue numbers currently even though we are rolled out in over 50 IMED clinics.
Appreciate anything those present can share.
Hope the Vino and horderves are up to scratch with the current cash burn.
Unfortunately working to counter my paper losses however hope...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
0.015(2.70%) |
Mkt cap ! $223.0M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 58.0¢ | 55.5¢ | $384.8K | 685.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10352 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 3951 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |